Market cap
Current P/E
166.67x
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Pharming Group N. V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks.

Similar securities

Based on sector and market capitalization

Report issue